<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BDTX
Black Diamond Therapeutics
$
()


  • Black Diamond Therapeutics announces changes to board of directors

    4/11/2024 - 08:15am
  • Black Diamond Therapeutics presents preclinical data on BDTX-1535 at AACR

    4/8/2024 - 05:53am
  • Black Diamond Therapeutics price target raised by $1 at H.C. Wainwright, here's why

    3/18/2024 - 06:12am
  • Black Diamond Therapeutics expects cash to fund requirements into 2Q25

    3/12/2024 - 08:02am
  • Black Diamond Therapeutics reports Q4 EPS (34c), consensus (47c)

    3/12/2024 - 08:02am
  • Black Diamond Therapeutics announces corporate update, expected 2024 milestones

    1/4/2024 - 08:21am
  • Black Diamond Therapeutics announces results from Phase 1 trial of BDTX-1535

    12/13/2023 - 07:03am
  • Black Diamond Therapeutics expects cash to fund requirements into 1H25

    11/6/2023 - 07:48am
  • Black Diamond Therapeutics reports Q3 EPS (45c), consensus (49c)

    11/6/2023 - 07:46am
  • Black Diamond Therapeutics presents data from Phase 1 trial of BDTX-1535

    10/15/2023 - 06:49am
  • Black Diamond Therapeutics appoints Velleca as CEO

    9/18/2023 - 07:02am
  • Black Diamond Therapeutics doses first patient in Phase 1 trial of BDTX-1535

    9/11/2023 - 08:25am
  • Fly Intel: Pre-market Movers

    8/11/2023 - 09:03am
  • Black Diamond Therapeutics expects cash to fund requirements into 1H25

    8/11/2023 - 07:32am
  • Black Diamond Therapeutics reports Q2 EPS (52c), consensus (54c)

    8/11/2023 - 07:32am
dynamic_feed Breaking News